HomeKURN • SWX
add
Kuros Biosciences AG
Previous close
CHF 6.40
Day range
CHF 6.18 - CHF 6.63
Year range
CHF 1.25 - CHF 8.40
Market cap
238.89M CHF
Avg Volume
244.35K
P/E ratio
-
Dividend yield
-
Primary exchange
SWX
Market news
Financials
Income Statement
Revenue
Net income
(CHF) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 10.35M | 173.78% |
Operating expense | 9.28M | 74.80% |
Net income | -4.34M | 20.37% |
Net profit margin | -41.91 | 70.92% |
Earnings per share | — | — |
EBITDA | -1.55M | 52.74% |
Effective tax rate | -2.46% | — |
Balance Sheet
Total assets
Total liabilities
(CHF) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 14.21M | -40.96% |
Total assets | 71.46M | -13.84% |
Total liabilities | 14.75M | 4.73% |
Total equity | 56.71M | — |
Shares outstanding | 36.77M | — |
Price to book | 4.16 | — |
Return on assets | -7.22% | — |
Return on capital | -8.76% | — |
Cash Flow
Net change in cash
(CHF) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -4.34M | 20.37% |
Cash from operations | -1.05M | -299.81% |
Cash from investing | -117.00K | 28.66% |
Cash from financing | 69.00K | -95.93% |
Net change in cash | -1.33M | -205.78% |
Free cash flow | -338.00K | 74.34% |
About
Founded
2016
Website
Employees
80